MedTrace Logo

Characteristics of SARS-CoV-2 Reinfection

NCT05748262 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1144

Last updated 2023-02-28

No results posted yet for this study

Summary

As the COVID-19 pandemic continues and the number of individuals with previous infection rises, numbers of SARS-CoV-2 reinfection are increasing. The second Omicron wave in Shanghai, China caused by BA.5-sublineages led to a large fraction of reinfections among BA.2 primary infections. To better understand the SARS-CoV-2 reinfection rate and clinical severity of reinfections, the investigators conducted a multi-centre cohort study. The investigators hope to provide valuable clinical evidences for reinfections and offer guidance for future policy making.

Conditions

Sponsors & Collaborators

  • Jiming Zhang

    lead OTHER

Principal Investigators

  • Jiming Zhang, PhD · Huashan Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-15
Primary Completion
2023-03-20
Completion
2023-03-20

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05748262 on ClinicalTrials.gov